Cyclarity Therapeutics
PrivateLast Round
Series A
Dec 30, 2024
Est. Valuation
$30.4M
Total Funding Raised
$24.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cyclarity Therapeutics is a biotechnology company that develops drugs to prevent and treat age-related conditions such as atherosclerosis by targeting and removing toxic forms of cholesterol.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyclarity Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Cyclarity Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 30, 2024 | ||||
| SAFE | Jul 19, 2023 | ||||
| Seed | Sep 23, 2021 | ||||
| Seed | Nov 14, 2019 |
Cyclarity Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kizoo Technology Capital | Seed |
| VitaDAO | SAFE, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 38% MoM, reaching 4K.
- Apr 26, 2026
Grew 19% QoQ from 16 to 19 employees.
Cyclarity Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cyclarity Therapeutics's valuation, stock price, and market status.